Future Path Medical Holding Company, LLC
CONCORD, OH · Founded 2008 · CIK 0001569602 · Biotech
Pathogen-free genetically modified pigs for xenotransplantation
future.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.6M
- 5 Form D · Dec 2014
- 142 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2012201320142015
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $497,000 | |
| Private capital raised | Form D · SEC | $1,080,001 | |
| Private capital raised | Form D · SEC | $1,533,335 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $1,466,668 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $976,091 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1805 | F.D.G. MINING INC. | — | $50K |
| 1806 | Andon Bio Inc. | — | $250K |
| 1807 | Chia Inc. | — | $28M |
| 1808 | Future Path Medical Holding Company, LLC | — | $2.6M |
| 1809 | ImmunityBio, Inc. | — | $633M |
| 1810 | MODERN MEADOW | — | $53M |
| 1811 | Sapience Therapeutics Inc. | — | $8.3M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Anthony BoiarskiExecutive Officer
- Peter BrumbergsExecutive Officer
- V BryantExecutive Officer
- Brian GilbertExecutive Officer
- Delmar MolherExecutive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.